PHASE-II STUDY OF CARBOPLATIN AND CYTOSINE-ARABINOSIDE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA

被引：5
|
作者：
MULDER, NH [1 ]
SLEIJFER, DT [1 ]
DEVRIES, EGE [1 ]
KOOPS, HS [1 ]
WILLEMSE, PHB [1 ]
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT SURG ONCOL,9713 EZ GRONINGEN,NETHERLANDS
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1990年 / 116卷 / 03期
关键词：
Chemotherapy; Malignant melanoma;
D O I：
10.1007/BF01612907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. © 1990 Springer-Verlag.
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [1] CARBOPLATINUM AND CYTOSINE-ARABINOSIDE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA - A PHASE-II STUDY
    JEREMIC, B
    DJURIC, L
    MIJATOVIC, L
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 277 - 280
  • [2] PHASE-II STUDY OF TAMOXIFEN IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    INGLE, JN
    GREEN, SJ
    AHMANN, DL
    JIANG, NS
    CANCER TREATMENT REPORTS, 1980, 64 (2-3): : 199 - 201
  • [3] PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA
    NOLTE, H
    GJEDDE, SB
    LINDEGAARDMADSEN, E
    BERGH, J
    BLOMQUIST, E
    MOURIDSEN, HT
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 655 - 657
  • [4] PHASE-II STUDY OF MITOMYCIN IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    EDMONSON, JH
    AHMANN, DL
    CHANG, M
    CANCER TREATMENT REPORTS, 1985, 69 (12): : 1451 - 1452
  • [5] PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA
    GJEDDE, SB
    MOURIDSEN, HT
    LMADSEN, E
    JENSEN, NV
    BLOMQUIST, E
    BERGH, J
    SODERBERG, M
    WAHLBY, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) : 566 - 566
  • [6] PHASE-II STUDY OF MAYTANSINE AND CHLOROZOTOCIN IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    AHMANN, DL
    FRYTAK, S
    KVOLS, LK
    HAHN, RG
    EDMONSON, JH
    BISEL, HF
    CREAGAN, ET
    CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 721 - 723
  • [7] PHASE-II STUDY OF AN AZIRIDINYLBENZOQUINONE (AZQ) IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    SCHUTT, AJ
    AHMANN, DL
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1982, 66 (12): : 2089 - 2090
  • [8] PHASE-II TRIAL OF CARBOPLATIN IN ADVANCED MALIGNANT-MELANOMA
    EVANS, LM
    CASPER, ES
    ROSENBLUTH, R
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 171 - 172
  • [9] PHASE-II EVALUATION OF PALA AND AMSA FOR PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    INGLE, JN
    PURVIS, JD
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 169 - 169
  • [10] PHASE-II STUDY OF RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    LONG, HJ
    FRYTAK, S
    SHERWIN, SA
    CHANG, MN
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 843 - 844
12345